1
Efficacy and Safety of Amantadine Hydrogen Chloride (HCl) ER Tablets in Parkinson’s Disease Subjects With LID
Condition(s):Parkinson’s Disease; Levodopa Induced Dyskinesia (LID)Last Updated:February 16, 2022Terminated
Amantadine HCl: 196 Clinical Trials, Page 1 of 20
Hide Studies Not Open or Pending
2
Efficacy and Safety of Amantadine Hydrochloride (HCl) ER Tablets to Treat Parkinson’s Disease Patients With LID.
Condition(s):Parkinson’s Disease; Levodopa Induced Dyskinesias (LID)Last Updated:February 16, 2022Terminated
3
Acetyl-Amantadine as a Biomarker in Patients With Glioblastoma
Condition(s):Glioblastoma MultiformeLast Updated:August 31, 2023Recruiting
4
Oral Amantadine, IV Amantadine and Hemodynamic Response to Laryngoscopy
Condition(s):Intubation, IntratrachealLast Updated:November 16, 2021Recruiting
5
Amantadine in Treating Cognitive & Motor Impairments in Adolescents and Adults With Cerebral Palsy
Condition(s):Cerebral PalsyLast Updated:May 31, 2022Terminated
6
Oral Amantadine Versus Gabapentin to Attenuate the Response to Laryngoscopy and Tracheal Intubation
Condition(s):Effect of Laryngoscopy and Tracheal IntubationLast Updated:September 25, 2018Completed
7
The Effect of Amantadine on Post-COVD-19 Fatigue
Condition(s):Post-COVID-19 SyndromeLast Updated:December 28, 2022Not yet recruiting
8
Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia
Condition(s):Dyskinesia; Levodopa-Induced Dyskinesia (LID); Parkinson’s Disease (PD)Last Updated:January 10, 2018Completed
9
Open-Label Safety Study of ADS-5102 in PD Patients With LID
Condition(s):Dyskinesia; Levodopa Induced Dyskinesia (LID); Parkinson’s Disease (PD)Last Updated:October 6, 2020Completed
10
Amantadine to Speed Awakening After Cardiac Arrest
Condition(s):Coma; Heart Arrest; AnoxiaLast Updated:December 4, 2019Completed